Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

Vote based on totality of scientific evidence provided by the Company including safety and efficacy data
NEW BRUNSWICK, N.J., Feb. 26, 2021 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Com… [read more]

Leave a Comment